Lifespan at Rhode Island Hospital — Providence, Rhode Island

Lifespan at Rhode Island Hospital is a clinical research site located in Providence, Rhode Island, United States 02903.

Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.

Lifespan at Rhode Island Hospital has participated in 3 clinical trials with 3 currently active.

Therapeutic areas: Sickle Cell Disease, Immunoglobulin A Nephropathy (IgAN).

Sponsors: Agios Pharmaceuticals, Inc., Biogen.

Sponsor Feasibility Report

Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lifespan at Rhode Island Hospital?

Lifespan at Rhode Island Hospital has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lifespan at Rhode Island Hospital conducted?

Lifespan at Rhode Island Hospital has 3 clinical trials on record, with 3 currently active. Their work covers Sickle Cell Disease, Immunoglobulin A Nephropathy (IgAN).

Is Lifespan at Rhode Island Hospital accredited by Crixeo Health?

Lifespan at Rhode Island Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Lifespan at Rhode Island Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.